Skip to content

Validity and Reliability of the Turkish Version of the McMaster University Head and Neck Radiotherapy Questionnaire

Validity and Reliability of the Turkish Version of the McMaster University Head and Neck Radiotherapy Questionnaire

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04269148
Enrollment
90
Registered
2020-02-13
Start date
2020-03-13
Completion date
2021-12-31
Last updated
2021-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer, Quality of Life

Brief summary

More than half of the patients with head and neck cancer are locally advanced patients. Radiotherapy is the primary treatment option for many patients with stage III and stage IV diagnosed with head and neck cancer. Radiation often causes tissue reactions by increasing local symptoms of the tumor and adding new symptoms to them. The acute effects of radiation are pain and burns associated with mucosal irritations and skin irritations, the root smell of the necrotic tumor and damaged normal tissues, dry skin, skin irritation, pain and dryness of mucosal membranes, decreased appetite, loss of chewing and swallowing skills, and hoarseness. The aim of this study is to make the validity, reliability and cultural adaptation of McMaster University Head and Neck Radiotherapy Inventory in Turkish.

Detailed description

Although there are various surveys in the literature that evaluate the quality of life of head and neck cancer patients, apart from the McMaster University Head and Neck Radiotherapy Questionnaire, there is no other questionnaire designed specifically for local advanced stage III and stage IV head and neck cancer and treatment of specific morbidity at a certain time. Patients in these stages often have difficulties in oral communication, nutritional disorders and loss of chewing and swallowing skills leading to dehydration, bad mouth odors, appearance problems affecting social and family life, and often significant morbidity including severe pain symptoms.

Interventions

Quality of life will be measured using McMaster University Head and Neck Radiotherapy Questionnaire and The Functional Assessment of Cancer Therapy - Head and Neck Cancer Version 4

Sponsors

Gazi University
CollaboratorOTHER
Izmir Bakircay University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Voluntarily accepting to participate in the study * Patients whose native language is Turkish * Undergoing or receiving radiotherapy treatment * At least 3 weeks have passed since the beginning of radiotherapy

Exclusion criteria

* The patient does not have sufficient functions of bone marrow, liver and kidney * To have scored less than 70 from Karnofsky Performance Scale

Design outcomes

Primary

MeasureTime frameDescription
McMaster University Head and Neck Radiotherapy QuestionnaireAt baselineMcMaster University Head and Neck Radiotherapy Questionnaire: This questionnaire includes 22 questions covering signs and symptoms related to 6 categories: oral cavity, throat, skin, digestive system, energy and psychosocial. n each category, there are at least 3 questions related to that category. There are 7 possible answer options in each question using Likert scale. High scores obtained according to the scoring system used indicate low toxicity. The final score of the survey is expressed as the average of the scores from 22 questions. In addition, the independent scores of each category are the average of the scores from the questions belonging to that category \[1\].

Secondary

MeasureTime frameDescription
The Functional Assessment of Cancer Therapy - Head and Neck Cancer Version 4At baselineThis scale consists of 5 categories that evaluate physical (7 items), social (7 items), emotional (6 items), functional status (7 items) and a subscale consisting of 11 questions specifically developed for head and neck cancer. In this assessment consisting of 38 items in total, each field can be scored among themselves and a total score is also calculated. The increase in the total score shows that the quality of life is higher. Each item is scored by patients with a Likert type classification ranging from 0 (none) to 4 (too many).

Countries

Turkey (Türkiye)

Contacts

Primary ContactKadirhan Ozdemir, PhD.
kadirhanozdemir@gmail.com+905069439059

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026